Cargando…
Adverse drug reactions of itolizumab in COVID-19 patient: A case report
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846913/ https://www.ncbi.nlm.nih.gov/pubmed/36537408 http://dx.doi.org/10.4103/ijp.ijp_803_21 |
_version_ | 1784871306970267648 |
---|---|
author | Mohammed, Ziauddin Suryachandra, Kandi Dandekar, Manoj P. |
author_facet | Mohammed, Ziauddin Suryachandra, Kandi Dandekar, Manoj P. |
author_sort | Mohammed, Ziauddin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9846913 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-98469132023-01-19 Adverse drug reactions of itolizumab in COVID-19 patient: A case report Mohammed, Ziauddin Suryachandra, Kandi Dandekar, Manoj P. Indian J Pharmacol Letter to the Editor Wolters Kluwer - Medknow 2022 2022-12-13 /pmc/articles/PMC9846913/ /pubmed/36537408 http://dx.doi.org/10.4103/ijp.ijp_803_21 Text en Copyright: © 2022 Indian Journal of Pharmacology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Letter to the Editor Mohammed, Ziauddin Suryachandra, Kandi Dandekar, Manoj P. Adverse drug reactions of itolizumab in COVID-19 patient: A case report |
title | Adverse drug reactions of itolizumab in COVID-19 patient: A case report |
title_full | Adverse drug reactions of itolizumab in COVID-19 patient: A case report |
title_fullStr | Adverse drug reactions of itolizumab in COVID-19 patient: A case report |
title_full_unstemmed | Adverse drug reactions of itolizumab in COVID-19 patient: A case report |
title_short | Adverse drug reactions of itolizumab in COVID-19 patient: A case report |
title_sort | adverse drug reactions of itolizumab in covid-19 patient: a case report |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846913/ https://www.ncbi.nlm.nih.gov/pubmed/36537408 http://dx.doi.org/10.4103/ijp.ijp_803_21 |
work_keys_str_mv | AT mohammedziauddin adversedrugreactionsofitolizumabincovid19patientacasereport AT suryachandrakandi adversedrugreactionsofitolizumabincovid19patientacasereport AT dandekarmanojp adversedrugreactionsofitolizumabincovid19patientacasereport |